Trial intelligence / Profile preview

Olopatadine vs Azelastine with Fluticasone in Seasonal Allergic Rhinitis

NCT00845195Phase 4Completed

Sponsor
Alcon Inc.
Start
Mar 2009
Primary completion
May 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of olopatadine in seasonal allergic rhinitis (SAR), sponsored by Alcon Inc.. Started Mar 2009; status: completed.

02

Drugs

olopatadine
03

Conditions

seasonal allergic rhinitis (SAR)

Beyond the preview

Go deeper on NCT00845195.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00845195.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call